MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,821,990 | +1014.2% | 4,382,199 | +1285.0% | 0.02% | +1050.0% |
| Q2 2023 | $3,933,014 | +2693745.2% | 316,413 | +2944.5% | 0.00% | – |
| Q1 2023 | $146 | -99.6% | 10,393 | -99.6% | 0.00% | -100.0% |
| Q4 2022 | $37,571 | -99.9% | 2,625,548 | +38.9% | 0.02% | -25.0% |
| Q3 2022 | $48,254,000 | +797.4% | 1,890,074 | +898.7% | 0.03% | +833.3% |
| Q2 2022 | $5,377,000 | -77.1% | 189,253 | -71.5% | 0.00% | -75.0% |
| Q1 2022 | $23,443,000 | +7.3% | 664,679 | +27.4% | 0.01% | +9.1% |
| Q4 2021 | $21,856,000 | +17.6% | 521,619 | +37.7% | 0.01% | 0.0% |
| Q3 2021 | $18,589,000 | +17.6% | 378,750 | +0.0% | 0.01% | +10.0% |
| Q2 2021 | $15,801,000 | +21.3% | 378,650 | +3.6% | 0.01% | +11.1% |
| Q1 2021 | $13,030,000 | -34.2% | 365,605 | -48.2% | 0.01% | -35.7% |
| Q4 2020 | $19,795,000 | – | 705,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |